-
Angiotensin III: A Sequence-Aware Assay Guide
2026-09-22
Angiotensin III is a sequence-defined RAAS peptide for resolving aldosterone, renin, receptor, and pressor biology. This guide connects its validated product attributes with a recent spike–receptor binding study to improve assay design without overstating translational evidence.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-22
Separate nanoparticle uptake from productive translation with one Cy5-labeled mRNA reagent and an EGFP functional readout. This practical workflow supports targeted LNP screening, macrophage studies, and quantitative optimization without relying on secondary mRNA detection.
-
L-Threonine: Metabolic Context for ALP Assays
2026-09-21
L-Threonine is an essential amino acid with important roles in protein synthesis, nutrient signaling, and metabolic profiling. This article presents a decision framework for using threonine biology alongside metal-free nanozyme-based alkaline phosphatase assays without confusing nutritional effects with direct enzyme inhibition.
-
EdU Flow Cytometry Assay Kits (Cy5) Workflow Guide
2026-09-21
EdU Flow Cytometry Assay Kits (Cy5) convert short DNA-replication pulses into quantitative, multiplex-compatible flow cytometry data. This workflow guide shows how to apply the assay to cancer cell proliferation, genotoxicity, and pharmacodynamic studies while avoiding common fixation, click-reaction, and Cy5 compensation errors.
-
CX-5461 Drives Mitotic Catastrophe in Cervical Cancer
2026-09-20
The reference study shows that the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by coupling DNA damage and ATM/ATR activation to aberrant mitotic entry. Its ability to enhance cisplatin sensitivity provides a mechanistic rationale for investigating Pol I inhibition in treatment-resistant cervical cancer, while also highlighting the need for careful validation in resistant and in vivo models.
-
Capsazepine as a Mechanistic Control in Pain Assays
2026-09-19
Capsazepine is a TRPV1 ion channel antagonist that can partition receptor-driven nociception from broader inflammatory and affective responses. This guide develops a concentration-aware assay strategy grounded in recent cannabidiol pain research and cross-channel pharmacology.
-
B7H3×CD3 BiTE mRNA-LNPs for Cancer Therapy
2026-09-18
The reference study developed an ionizable lipid nanoparticle system for delivering mRNA encoding a B7H3×CD3 bispecific T-cell engager. Its results show that transient in vivo mRNA expression can generate therapeutically relevant BiTE exposure, prolong protein persistence, and produce durable antitumor activity in preclinical models of hematologic malignancy and melanoma.
-
UTP Solution (100 mM) for RNA Workflows
2026-09-18
UTP Solution is a 100 mM aqueous source of Uridine-5'-triphosphate trisodium salt for RNA synthesis workflows. Its HPLC-verified purity, nuclease-free specification, and cold-storage guidance support controlled in vitro transcription, RNA amplification, and siRNA synthesis.
-
Redox-Responsive Peptide Coacervates for mRNA Delivery
2026-09-17
The reference study introduces HBpep-SS4, a single-component peptide coacervate whose cysteine-derived disulfide bonds provide both structural organization and glutathione-responsive intracellular release. Its ability to package diverse RNA cargos and support genome editing highlights a useful design strategy for mRNA delivery, while the cell-based evidence also defines important limits for translation to animal studies.
-
Drug Response Assays: Viability Versus Cell Death
2026-09-17
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing why growth inhibition and actual cell killing should not be treated as interchangeable endpoints. This framework supports more precise interpretation of in vitro cancer-drug responses by considering response magnitude, composition, and timing.
-
HyperScript RT SuperMix for qPCR Workflow
2026-09-16
HyperScript RT SuperMix for qPCR simplifies two-step qRT-PCR when RNA is scarce, structured, or variable in quality. This workflow shows how to apply it to ZNF706 gene expression analysis in hepatocellular carcinoma while preserving controls, reproducibility, and assay flexibility.
-
Avian Hair Cell Regeneration: A Practical Protocol
2026-09-16
Sato et al. provide an integrated protocol for inducing auditory hair cell loss in living chickens and tracking regeneration with multiplexed mRNA detection, immunohistochemistry, and EdU labeling. Its main contribution is methodological: it connects a reproducible lesion model with spatial and cell-cycle readouts that can clarify how avian sensory epithelia recover.
-
L-Threonine Workflows for Metabolic and ALP Research
2026-09-15
L-Threonine is a controllable nutrient variable for cell culture optimization, amino acid biosynthesis studies, and metabolic profiling—not a direct alkaline phosphatase inhibitor. This guide pairs practical L-Threonine workflows with a metal-free carbon-dot ALP assay to separate metabolic effects from enzymatic readout artifacts.
-
Ultrasonic Polylactide Micelles for Paclitaxel Delivery
2026-09-15
Stepanova and colleagues describe an ultrasonic film-rehydration method that produces mixed polylactide micelles in 15–20 minutes rather than over several days. The resulting particles showed narrow size distribution, colloidal and enzymatic stability, low cytotoxicity, and paclitaxel activity comparable to a commercial formulation, supporting their use as a delivery-platform model in cancer research.
-
Pheromone-Driven Neurodegeneration in C. elegans
2026-09-14
Peng et al. show that pheromone exposure during the L1 stage can reprogram neurodevelopment and accelerate neurodegeneration in adult C. elegans. The study identifies convergent ASK and ASI sensory pathways, AIA interneurons, insulin-like signaling, and neuronal autophagy as a mechanistic chain linking early environmental perception to later proteostasis failure.